AER under 314.80 (marketing applications) - quarterly reports

Postmarketing Adverse Drug Experience Reporting

0230 GFI Periodic Postmarket Reports in ICH E2C(R2) Format

AER under 314.80 (marketing applications) - quarterly reports

OMB: 0910-0230